On February 27, 2024, a Schedule 13G was filed with the U.S. Securities and Exchange Commission by several entities, indicating a collective beneficial ownership of 115,482 ordinary shares of SciSparc Ltd., which represents 9.99% of the company's class of securities. The reporting entities include YA II PN, Ltd., YA Global Investments II (U.S.), LP, Yorkville Advisors Global, LP, Yorkville Advisors Global II, LLC, YA II GP, LP, YAII GP II, LLC, Mark Angelo, and SC-Sigma Global Partners, LP. These shares consist of direct ownership and the right to acquire additional shares under a Standby Equity Purchase Agreement (SEPA) with SciSparc Ltd. The entities have agreed to file this statement jointly, and each entity disclaims beneficial ownership of the securities owned by the others. The filing indicates that the shares were not acquired for the purpose of changing or influencing the control of SciSparc Ltd.

On February 27, 2024, a Schedule 13G was filed with the U.S. Securities and Exchange Commission by several entities, indicating a collective beneficial ownership of 115,482 ordinary shares of SciSparc Ltd., which represents 9.99% of the company's class of securities. The reporting entities include YA II PN, Ltd., YA Global Investments II (U.S.), LP, Yorkville Advisors Global, LP, Yorkville Advisors Global II, LLC, YA II GP, LP, YAII GP II, LLC, Mark Angelo, and SC-Sigma Global Partners, LP. These shares consist of direct ownership and the right to acquire additional shares under a Standby Equity Purchase Agreement (SEPA) with SciSparc Ltd. The entities have agreed to file this statement jointly, and each entity disclaims beneficial ownership of the securities owned by the others. The filing indicates that the shares were not acquired for the purpose of changing or influencing the control of SciSparc Ltd.